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Human expeditions to Mars will require adaptation to the 24.65-h Martian solar day-night cycle (sol), which is outside the
range of entrainment of the human circadian pacemaker under lighting intensities to which astronauts are typically exposed.
Failure to entrain the circadian time-keeping system to the desired rest-activity cycle disturbs sleep and impairs cognitive
function. Furthermore, differences between the intrinsic circadian period and Earth’s 24-h light-dark cycle underlie human
circadian rhythm sleep disorders, such as advanced sleep phase disorder and non-24-hour sleep-wake disorders. Therefore,
first, we tested whether exposure to a model-based lighting regimen would entrain the human circadian pacemaker at
a normal phase angle to the 24.65-h Martian sol and to the 23.5-h day length often required of astronauts during short
duration space exploration. Second, we tested here whether such prior entrainment to non-24-h light-dark cycles would lead
to subsequent modification of the intrinsic period of the human circadian timing system. Here we show that exposure to
moderately bright light (,450 lux; ,1.2 W/m
2) for the second or first half of the scheduled wake episode is effective for
entraining individuals to the 24.65-h Martian sol and a 23.5-h day length, respectively. Estimations of the circadian periods of
plasma melatonin, plasma cortisol, and core body temperature rhythms collected under forced desynchrony protocols
revealed that the intrinsic circadian period of the human circadian pacemaker was significantly longer following entrainment
to the Martian sol as compared to following entrainment to the 23.5-h day. The latter finding of after-effects of entrainment
reveals for the first time plasticity of the period of the human circadian timing system. Both findings have important
implications for the treatment of circadian rhythm sleep disorders and human space exploration.
Citation: Scheer FAJL, Wright KP Jr, Kronauer RE, Czeisler CA (2007) Plasticity of the Intrinsic Period of the Human Circadian Timing System. PLoS
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INTRODUCTION
The daily pattern of sleep and wakefulness is regulated by
homeostatic and circadian processes [1,2]. The master circadian
pacemaker, located in the suprachiasmatic nucleus of the anterior
hypothalamus (SCN), orchestrates near-24-h rhythms in physiol-
ogy and behavior in mammals, including the sleep-wake cycle
[3,4]. Environmental light exposure can shift the phase of the
circadian timing system depending on properties of the light
exposure such as timing, intensity, duration, and wavelength [5–
8]. Entrainment at a normal phase angle requires daily phase shifts
that compensate for the difference between the intrinsic circadian
period and the imposed light-dark cycle (T-cycle) and result in the
elevated production of the soporific hormone melatonin during the
scheduled sleep episode and minimal melatonin production during
the scheduled wake episode. Failure of proper entrainment of the
circadian time keeping system to the desired sleep-wake cycle
disturbs sleep and impairs cognitive function [9,10]. In the present
study, we tested two hypotheses: (1) that the human circadian
pacemaker can be entrained at a normal phase angle to non-24-h
rest-activity cycles; and (2) that the period of the human circadian
pacemaker would show plasticity following entrainment to non-24-
h rest-activity cycles.
It was not known whether the human circadian timing system
could be entrained at a normal phase angle to both a shorter-than
and longer-than 24-h rest-activity cycle without relying on
exposure to artificial bright light, which is not available on any
spacecraft built to date. Given initial reports that the period of the
human circadian pacemaker was close to 25 h [11,12], it had been
presumed that the human circadian sleep-wake cycle would
readily synchronize to the 24.65-h solar day-night cycle (sol) on the
planet Mars. However, the more recent discovery that the intrinsic
period of the human circadian pacemaker is very close to 24 h
(i.e., 24.18 h) [13] led to the subsequent demonstration that the
human circadian pacemaker is unable to entrain to either the
Martian day (24.65 h) or the 23.5-h sleep-wake cycle often
required of astronauts during space shuttle missions under the
rather dim lighting conditions to which astronauts are commonly
exposed [10,14]. Many other factors, in addition to dim light
aboard space crafts, may contribute to circadian misalignment
during space flight. Windows and exposure to sunlight of future
mission astronauts may be restricted during long duration space
flights because of dangerous particle radiation while traveling
outside the Earth’s protective magnetic field and while on Mars
because of radiation, sun-blocking dust storms, and extreme
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artificial light that is costly to generate, which is the primary reason
why ambient light is so dim on the International Space Station and
aboard the U.S. Space Shuttle fleet. Furthermore, to achieve
maximal phase resetting, a very bright light exposure
(,10,000 lux; 27 W/m
2) should be timed close to the circadian
core body temperature minimum, which would interfere with
normal timing of the sleep episode. In the present study, we
therefore evaluated whether exposure to only moderately bright
light limited to part of the scheduled wake episode could entrain
the human circadian pacemaker at a normal phase angle to the
Martian sol and to a 23.5-hour cycle. Given that the resetting
effects of light are both phase-dependent [7,15] and intensity-
dependent [5,6], we used Kronauer’s mathematical model of the
resetting effect of light on the human circadian pacemaker [16] to
design a temporal pattern of environmental light exposure
consisting of exposure to moderately bright light (,450 lux;
,1.2 W/m
2) for half of each of the scheduled wake episodes
(second or first half, see Methods for details).
The period of the circadian timing system is genetically
determined, involving transcription-translation feedback loops of
clock genes [17,18]. The period of the circadian pacemaker
influences morning-eveningness preferences [19] and is important
in the pathophysiology of certain circadian rhythm sleep disorders.
Polymorphisms of clock genes such as Per2 and Per3 have been
associated with advanced sleep phase disorder, delayed sleep phase
disorder, and diurnal preference [20–23]. Furthermore, if
a difference between the period of the circadian pacemaker and
the period of the Earth’s rotation cannot be corrected by daily
time cues, this can lead to non-24-hour sleep-wake disorder, as
often observed in completely blind individuals [24,25]. Data in
non-humans indicate that the near-24-h circadian period may be
modified by prior environmental conditions, notably the period of
the imposed light-dark cycle [26]. If the human circadian period
would show such plasticity, this would have important implications
for the treatment of circadian rhythm sleep disorders and for the
development of countermeasures for human space exploration.
We therefore tested the second hypothesis that the period of the
circadian pacemaker in humans would be modified following
entrainment to non-24-h day lengths, such that the intrinsic
circadian period would be lengthened following entrainment to
a longer-than 24-h day-night cycle (i.e., 24.65-h) as compared to
the intrinsic circadian period following entrainment to a shorter-
than 24-h day-night cycle (i.e., 23.5-h). We have measured the
period of plasma melatonin, plasma cortisol, and core body
temperature rhythms under controlled conditions of a forced
desynchrony (FD) protocol to estimate intrinsic circadian period
immediately following release from entrainment to each of these
two day lengths [13].
RESULTS
Testing the first hypothesis, we found that the model-based
lighting regimen were effective at entraining the melatonin rhythm
to the 23.5-h and 24.65-h rest-activity cycles (Figure 1 and 2). The
phase angles of entrainment between the 25% dim light melatonin
onset (DLMOn25%) and bedtime and between the 25% dim light
melatonin offset (DLMOff25%) and scheduled waketime during the
constant posture (CP) protocol following the 23.5-h rest-activity
cycles did not significantly change as compared to those phase
angles during the baseline CP protocol (Figure 2A). This shows
that the lighting regimen resulted in daily phase advances required
to maintain entrainment to the 23.5-h rest-activity cycles. In fact,
the DLMOn25% relative to bedtime and the DLMOff25% relative
to scheduled waketime during the CP protocol following the
24.65-h light-dark cycles were significantly later by 1 h and
42 min (P,0.01) and 1 h and 40 min (P,0.05), respectively, as
compared to their timing during the baseline CP protocol
(Figure 2A). This shows that the lighting regimen resulted in even
larger daily phase delays than required to maintain entrainment to
the 24.65-h rest-activity cycle. Both lighting regimens furthermore
maintained a phase angle of entrainment such that melatonin
levels remained high during the scheduled sleep episodes and low
during the scheduled wake episodes following the two-week 23.5-
hour and two-week 24.65-hour sleep-wake cycle.
During the shorter-than-24-h rest-activity cycle, the observed
period for the group was not different from the imposed 23.5-h
cycle (23.49 h; 95% confidence interval [95% CI]: 23.46–23.53 h;
Figure 2B). The 95% CI of the individual observed period
overlapped 23.5 h for 5 subjects. For two subjects the estimate of
observed period deviated by 21o r+4 min from 23.5 h (2280 and
18G6, respectively). During the longer-than 24-h rest-activity
cycle, the observed period for the group was not different from the
imposed 24.65-h cycle (24.70 h; 24.65–24.76 h). The 95% CI of
the individual observed period overlapped 24.65 h for 5 subjects.
For two subjects the estimate of observed period deviated by +4o r
+10 min from 24.65 h (18G6 and 2195, respectively).
Testing the second hypothesis, we found that the intrinsic
circadian periods of the plasma melatonin (0.0560.01 h;
P=0.002), plasma cortisol data (0.1460.03 h; P=0.004), core
body temperature data (0.1060.03 h; P=0.02), and the composite
[13] (0.1060.02 h; P=0.002), as assessed during the two-week FD
protocol, were significantly longer following entrainment to the
24.65-h day than following entrainment to the 23.5-h day
(Figures 1 and 3). There were no significant differences between
melatonin, cortisol, and temperature period assessments when
analyzed independently.
DISCUSSION
In this study, we developed a model-based lighting regimen that
was effective for entraining individuals at a normal phase angle to
the 24.65-h Martian sol and to a 23.5-h rest-activity cycle. Second,
we showed for the first time plasticity of the human circadian
timing system that regulates period, with prior entrainment to
non-24-h rest-activity and light-dark cycles resulting in long-term
changes in the intrinsic human circadian period (after-effects of
entrainment).
We have developed a robust countermeasure composed of
appropriately timed moderately bright light, dim light, and
darkness, based on the human phase response curve, intensity
response curve, and predictions from Kronauer’s mathematical
model of the effects of light on the human circadian pacemaker
[5–7,15,16] to entrain at an appropriate phase angle the human
circadian pacemaker to longer- and shorter-than 24-h day lengths.
The findings of the current study validate the application of this
mathematical model for the development of lighting counter-
measures for entrainment to non-24-h sleep-wake schedules
demanded by ground-based and flight-based space exploration
missions [10,14,27]. Similarly, for circadian sleep rhythm
disorders, where also differences between the intrinsic circadian
period and the desired rest-activity cycle compromise restorative
sleep and daytime cognitive functioning, the current findings may
help design treatment of these disorders. Based on the spectral
sensitivity of retinal photoreceptor systems involved in non-image-
forming photic responses, additional research should be conducted
to evaluate strategies to decrease further the light intensity or
duration required by optimizing wavelength [8,28]. Previous
studies have reported lighting schemes capable of entraining some
humans to non-24-h sleep-wake cycles [9,29–31]. However, all but
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at a normal phase angle and/or used unreliable circadian phase
markers (e.g., self-reported sleep-wake cycle or temperature phase
estimates that were masked [32] under ambulatory conditions)
[9,29,30]. A modulated light exposure composed of three different
light levels during scheduled wakefulness, including two 45-min
light pulses of 9,500 lux, was able to entrain subjects at a normal
phase angle to a T-cycle 1h longer than each subject’s intrinsic
circadian period [31]. The current study extends these findings by
showing that a simpler lighting regimen that includes 450 lux for
half of the wake episode can also be effective for entraining
subjects at a normal phase angle to a longer-than-24-h day and
a shorter-than-24-h day.
Furthermore, here we show that entrainment to a non-24-h
sleep-wake cycle can produce an ‘‘after-effect’’ on the intrinsic
circadian period in humans and thus demonstrates plasticity of the
human circadian timing system. Our finding of after-effects of
entrainment in humans demonstrates a fundamental property of
the circadian time keeping system in humans that is consistent with
that observed in non-humans [26]. The observed after-effects of
entrainment on the three different circadian phase markers, i.e.,
melatonin, cortisol, and core body temperature assessed during
two-week FD protocols, support the hypothesis that the after-
effects of entrainment measured in this study reflect plasticity of
the master circadian pacemaker located in the SCN. Whether
neural plasticity within the SCN plays a role in our current
observations will require further animal experimental studies [33].
Another example of plasticity of the circadian timing system is the
influence of prior light history on the sensitivity to a subsequent
light exposure, which has been shown for melatonin suppression
and phase shifting in rodents [34]. For humans, similar adaptation
to preceding light intensity has been published for melatonin
suppression [35–37]. Whether prior light history affects the phase
shifting response in humans has yet to be shown. A potential
underlying mechanism for adaptation of the circadian timing
system to background light exposure is adaptation of the
intrinsically photosensitive retinal ganglion cells, which drive
circadian phase-shifting and melatonin suppression via the SCN
[38]. It is unknown whether long-term depression of the electrical
activity of SCN neurons following light exposure is involved in the
observed adaptation of the circadian system to background light
history [39].
The magnitude of the after-effects of entrainment in the current
study (0.1 h), in which T-cycles that differed from 24 hours by 0.5
and 0.65 hours were imposed on the human subjects for 14 days,
was smaller than that observed in studies performed in mice in
which a gradually changing T-cycle that differed from 24 hours by
64 hours was imposed for approximately 50 days [26]. Further
research will be needed to determine whether the difference in the
magnitude of the after-effects observed in these studies was due to
species differences, the longer duration of exposure to the non-24-
h T-cycle, or the larger differences in the preceding T-cycles in
Figure 1. Raster plot of the study design for a representative individual (2478). The study protocol is double plotted such that consecutive days
are next to and beneath the other. Scheduled sleep episodes in complete darkness (horizontal black lines), exposure to moderately bright light
(parallelogram boxes with sun; part of wake episodes Days 6–19, 38–51), and CP procedures (open horizontal boxes; on Days 4–5, 20–21, 36–37, 52–
53, 68–69) are indicated. Except for the scheduled wake episodes during the baseline (Day 1–3) and recovery days (Day 70–73; ,90 lux [,0.23 W/
m
2]) and exposure to moderately bright light (,450 lux [,1.18 W/m2]), lights were dim throughout the study (,1.8 lux [,0.0048 W/m
2]).
DLMOn25% (green upward-triangles) and DLMOff25% (red downward-triangles) are shown during dim light conditions. The intrinsic circadian period of
the melatonin, cortisol, and temperature cycles during the FD protocols (Days 22–35, 54–67) were computed by a nonorthogonal spectral analysis
technique. The fitted phase of the minimum of core body temperature (gray dotted line) and of the maximum of plasma cortisol (black dashed line)
during the FD protocols are indicated. The observed circadian periods during the exposure to the 24.65-h day and to the 23.5-h day and the
composite estimate of the intrinsic circadian period as computed by averaging the intrinsic period estimate from plasma melatonin, plasma cortisol,
and core body temperature data (tcomposite) [13] for both FD protocols are indicated to the right of the figure.
doi:10.1371/journal.pone.0000721.g001
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compared to the current human study (23.5-h vs. 24.65-h T-
cycles). Moreover, entrainment to the more extreme T-cycles in
the animal experimental studies was achieved by gradually
lengthening or gradually shortening the T-cycle each day, which
may have influenced the observed after-effects. Unfortunately, it is
not known whether human subjects could be entrained to such
extreme T-cycles. Furthermore, it would have required 145 days
for each subject studied to duplicate the earlier mouse study,,
which would make such studies difficult to conduct in humans.
After-effects typically show a slow decay back to the intrinsic
circadian period over the course of many cycles; for example, in
mice and sparrow, after-effects on circadian period have been
reported to persist for ,100 cycles [26,40]. The two-week FD
protocols on which the period estimates were based in the current
study were too short to assess the time course of this decay in
humans.
Our finding of an after-effect of entrainment on circadian
period may help to explain, as least in part, the observed difference
in average circadian period between sighted individuals (,24.2 h)
and blind individuals not entrained to the 24-h day while living in
society (,24.5 h), although selection bias and other factors may
play an additional role in the longer average period reported in
non-entrained blind individuals [13,41]. This explanation is
corroborated in non-human mammals, in which the observed
circadian period upon release from entrainment to the 24-h day
has been reported to be closer to 24.0 h than following exposure to
constant darkness for an extended time or after blinding [42,43].
Also photoperiod, the fraction of the light episode relative to the
dark episode within a light-dark cycle, has been reported to affect
circadian period in mice and birds, with longer light episodes
shortening circadian period. Such differences could account for
seasonal variations in circadian timekeeping [26,40,44]. In animal
studies, it has been reported that even a single light exposure can
result in changes in the intrinsic circadian period that are
comparable in magnitude to after-effects of entrainment
[26,40,42]. If this were also the case in humans, then even a single
transmeridian flight (rapid travel across multiple time zones), with
a sudden shift in the timing of the light-dark cycle, could induce
changes in intrinsic circadian period. Such post-travel after-effects
in circadian period may affect the 50–100 million people who
experience jet travel each year. Similarly, these results suggest that
repeated shifts in the sleep-wake cycle and the circadian timing
Figure 2. Lighting regime was effective for entraining circadian
timing system to 24.65-h and 23.5-h rest-activity cycles. (A) The phase
angles of entrainment were not different between the CP protocols at
baseline and that following the 23.5-h days. The phase angles of
entrainment were significantly different between the CP protocols at
baseline and that following the 24.65-h days, such that the melatonin
DLMOn25% and DLMOff25% during the CP protocol following the 24.65-h
days relative to the scheduled sleep episode occurred even later than
during the baseline CP protocol. Therefore, the lighting regimes were
effective in maintaining entrainment to both non-24-h sleep-wake
cycles at an appropriate phase angle. During the CP protocol following
fourteen 23.5-h days (post 23.5-h), the timing of the scheduled sleep
episode occurred 7 clock hours earlier than during the CP protocol
preceding these shorter-than-24-h days. During the CP protocol
following fourteen 24.65-h days (post 24.65-h), the timing of the
scheduled sleep episode occurred 9.1 clock hours later than during the
CP protocol preceding these longer-than-24-h days. Open bars,
scheduled 8-h sleep episodes during CP protocols; green upward-
triangle, DLMOn25%; red downward-triangle, DLMOff25%; error bars,
SEM; *, P,0.01; **, P,0.005. (B) Light was effective for entraining the
circadian timing system, such that the observed circadian period was
similar to the period of the imposed non-24-hour sleep-wake cycles.
Vertical lines, 23.5-h and 24.65-h day-night cycles (T-cycles); Error bars,
95% confidence interval.
doi:10.1371/journal.pone.0000721.g002
Figure 3. Plasticity of the human circadian period. Intrinsic circadian
period was significantly longer following the 24.65-h day versus than
following the 23.5-h day, as estimated during two-week FD protocols in
dim light conditions. This was true when using plasma melatonin data
(P=0.002), plasma cortisol data (P=0.004), core body temperature data
(P=0.02), and the composite [13] (P=0.002) for period assessment, the
later depicted here. There were no significant differences between
melatonin, cortisol, and temperature period assessments. There was no
significant order effect. Small filled circles; individual changes in intrinsic
circadian period following exposure to both non-24-h day-night cycles
(post 24.65–post 23.5); large filled circle; group difference; error bars,
SEM.
doi:10.1371/journal.pone.0000721.g003
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changes in circadian period. Additional research is needed to
investigate long-term after-effects of travel across time zones and
shift work on human circadian period.
The findings of circadian entrainment to non-24-h sleep-wake
rhythms and after-effects on intrinsic circadian period following
entrainment have important implications for the development of
treatments for circadian rhythm sleep disorders, such as delayed
sleep phase disorder and advanced sleep phase disorder, in which
circadian sleep drive occurs much later or earlier than desired,
respectively. These findings may also influence development of
countermeasures for human adaptation to non-24-h-sleep-wake
schedules, as encountered by shift-workers, in jet lag, in submarine
naval operations, and during short-term and long-term human
space exploration [10,20,21,45]. The relative contribution of SCN
and extra-SCN tissue in after-effects of entrainment will require
further study [46]. Current genetic or neural plasticity models do
not include a mechanism that explains after-effects of entrainment.
Understanding the molecular and neural basis of after-effects of
entrainment could allow for a targeted strategy to optimize further
treatment of circadian rhythm sleep disorders and human space
exploration.
METHODS
Subjects
Seven healthy young men (age 22–40 yrs) completed the 73-day
in-laboratory studies. Subjects were free from medications and
drugs for the week prior and during the study. Subjects reported
no shift work for three years nor crossing more than one time zone
for three months prior to study. Subjects maintained a regular 8-h
sleep and 16-h wake schedule while living at home for three weeks
prior to study, as verified by sleep log, call-in times, and wrist
actigraphy (Actiwatch, Minimitter, Bend, OR). Subjects gave
written informed consent and the protocol was approved by the
Partners Human Research Committee.
In laboratory condition
Entrainment to non-24-h day lengths and after-effects of
entrainment on period were tested in a randomized, within-
subject, crossover design. Subjects lived in a personal laboratory
room free of time cues for 73 days. Ambient light and room
temperature were controlled and sleep opportunities and meals
were scheduled. Ceiling-mounted fluorescent lamps (Philips,
Eindhoven, The Netherlands) with a 4100-K color temperature
produced a spectrum of white light. Napping and exercise were
proscribed. After admission to the laboratory, subjects were
maintained on a 24-h sleep-wake cycle for three days (Figure 1).
This was followed by a 40-h CP protocol during which the subjects
were scheduled to sleep at their habitual times but maintained
a semi-recumbent posture in dim light conditions (0 lux during
scheduled sleep and ,1.8 lux [,0.0048 W/m
2] during wakeful-
ness) thereby allowing accurate assessment of intrinsic melatonin
phase. After the CP protocol, subjects were scheduled to a 24.65-h
or 23.5-h day for 14 cycles, maintaining a 2:1 wakefulness:bedrest
ratio. Given that the resetting effects of light are both phase-
dependent [7,15] and intensity-dependent [5,6], we used Kro-
nauer’s mathematical model [16] to design a temporal pattern of
environmental light exposure that would facilitate entrainment to
the Martian sol and to a 23.5-h day (Figure 1) with light exposure
following the circadian core body temperature minimum (i.e.,
morning) causing phase advances and with light exposure
preceding the circadian core body temperature minimum (i.e.,
evening) causing phase delays. During each of the 23.5-h and
24.65-h days, lights were moderately bright (,450 lux [,1.18 W/
m
2]) for approximately half of scheduled wakefulness (the first and
the second half, respectively), and dim (,1.8 lux) for the
remainder of scheduled wakefulness. The entrainment schedule
was followed by a second 40-h CP protocol and a two-week FD
protocol, composed of 28.0-h dim light–dark (,1.8 lux-0 lux)
activity–rest cycles, that was used to estimate the intrinsic
circadian period by assessing the subjects’ plasma melatonin,
plasma cortisol, and core body temperature rhythms [13]. The
duration of the wake episode of the third CP protocol was adjusted
for each subject to realign the sleep-wake cycle for the second half
of the study such that the phase angle between the core body
temperature minimum and scheduled waketime at the end of the
third CP protocol would be similar to that during the first
(baseline) CP protocol. Following the third CP protocol, subjects
were entrained to the other non-24-h cycle (23.5-h or 24.65-h,
respectively), again followed by a fourth CP protocol, circadian
period assessment during a two-week 28-h FD protocol, and a fifth
CP protocol. Following the fifth (final) CP protocol, subjects were
scheduled according to their habitual sleep-wake schedule for
three days to facilitate reentrainment to their habitual sleep-wake
cycle (Figure 1).
Analysis
Blood was sampled by an intravenous catheter at hourly intervals
throughout the FD protocols and CP protocols, and for three 2–3-
day sampling windows during the 23.5-h and 24.65-h entrainment
cycles. Plasma melatonin and cortisol levels were assayed via
radioimmunoassay I
125 (Pharmasan Laboratories, Osceola, WI,
USA). The sensitivity of the melatonin assay was 0.7 pg/mL and
the interassay coefficient of variation was 13.2% and 8.4% at
a mean concentration of 17.3 and 69 pg/mL, respectively. The
sensitivity of the cortisol assay was 0.11 mg/dL and the interassay
coefficient of variation was 7.9% and 6.8% at a mean concentra-
tion of 5.1 and 18.5 mg/dL, respectively. Core body temperature
was recorded continuously during the two FD protocols and the
five CP protocols every minute via a rectal thermister (Yellow
Springs Instrument Company, Yellow Springs, OH USA).
To distinguish definitively between entrainment and relative
coordination, a much longer inpatient study (.6–12 months) on
each non-24-h rest-activity cycle would have been required. We
have therefore used a classification method of entrainment that is
consistent with that used in our prior research [9,14] and with that
from studies of blind individuals [47,48]. Using this classification,
entrainment to the non-24-h sleep-wake cycles was defined as the
95% confidence interval (95% CI) of the observed circadian
period overlapping with the period of the imposed rest-activity
cycle. In addition, we tested whether subjects were entrained at
a normal phase angle, which was defined as a similar phase angle
of entrainment (i.e., timing of circadian timing system relative to
sleep-wake cycle) observed following the non-24-h-sleep wake
cycle as that observed at baseline (T=24 h) and tested with a 2-
tailed t test for dependent samples [9,14]. The observed circadian
period was estimated by linear regression of the DLMOn25% and
DLMOff25% times during the 23.5-h day-night cycle and the
24.65-h day-night cycle, respectively, after exclusion of the first 5
cycles, to minimize transient adjustments to imposed T cycles. The
phase angle of entrainment was assessed by comparing the timing
of the DLMOn25% and DLMOff25% relative to the scheduled
bedtime and scheduled waketime, respectively.
For assessment of the after-effects of entrainment, the intrinsic
circadian period following the 24.65-h days and following the
23.5-h days were compared and tested with a 2-tailed t test for
dependent samples. Circadian period estimates were based on
Human Circadian Timing System
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data collected during FD and were computed by a nonorthogonal
spectral analysis technique with an exact maximum likelihood
fitting procedure [13]. The composite estimate of the intrinsic
period for each subject was computed by averaging the intrinsic
circadian period estimates for plasma melatonin, plasma cortisol,
and core body temperature data [13]. Please refer to Text S1 for
supplementary materials and methods.
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